MedPath

Atenolol

Atenolol Tablets USP 25 mg, 50 mg and 100 mg

Approved
Approval ID

73671d55-3e10-cb1d-e053-2991aa0ac038

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Mar 15, 2021

Manufacturers
FDA

NuCare Pharmaceuticals,Inc.

DUNS: 010632300

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Atenolol

PRODUCT DETAILS

NDC Product Code68071-4527
Application NumberANDA077443
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateMarch 15, 2021
Generic NameAtenolol

INGREDIENTS (8)

HYPROMELLOSESInactive
Code: 3NXW29V3WO
Classification: IACT
GLYCERINInactive
Code: PDC6A3C0OX
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
POVIDONEInactive
Code: FZ989GH94E
Classification: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
ATENOLOLActive
Quantity: 50 mg in 1 1
Code: 50VV3VW0TI
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Atenolol - FDA Drug Approval Details